Zacks Small Cap Issues Negative Outlook for ARWR Earnings
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Zacks Small Cap lowered their Q2 2025 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a report issued on Wednesday, February 12th. Zacks Small Cap analyst D. Bautz now expects that the biotechnology company will post earnings per share of ($1.01) […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Zacks Small Cap lowered their Q2 2025 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a report issued on Wednesday, February 12th. Zacks Small Cap analyst D. Bautz now expects that the biotechnology company will post earnings per share of ($1.01) […]
